GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ccna2 | decreases expression | ISO | Ccna2 (Mus musculus) | 6480464 | CTD | Dexamethasone results in decreased expression of CCNA2 mRNA | PMID:21041162 | Ccna2 | increases expression | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | Dexamethasone results in increased expression of CCNA2 mRNA | PMID:23137833 | Ccna2 | multiple interactions | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CCNA2 mRNA | PMID:28628672 | Ccna2 | multiple interactions | ISO | Ccna2 (Mus musculus) | 6480464 | CTD | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNA2 protein; silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNA2 protein] | PMID:25559859 | |
Go Back to source page | Continue to Ontology report |